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A plethora of epidemiologic evidence from large studies supports unequivocally an inverse, independent, and graded association
between volume of physical activity, health, and cardiovascular and overall mortality. This association is evident in apparently
healthy individuals, patients with hypertension, type 2 diabetes mellitus, and cardiovascular disease, regardless of body weight.
Moreover, the degree of risk associated with physical inactivity is similar to, and in some cases even stronger than, the more
traditional cardiovascular risk factors. The exercise-induced health benefits are in part related to favorable modulations of
cardiovascular risk factors observed by increased physical activity or structured exercise programs. Although the independent
contribution of the exercise components, intensity, duration, and frequency to the reduction of mortality risk is not clear, it is
well accepted that an exercise volume threshold defined at caloric expenditure of approximately 1,000 Kcal per week appears to
be necessary for significant reduction in mortality risk. Further reductions in risk are observed with higher volumes of energy
expenditure. Physical exertion is also associated with a relatively low and transient increase in risk for cardiac events. This risk
is significantly higher for older and sedentary individuals. Therefore, such individuals should consult their physician prior to
engaging in exercise.

“Walking is man’s best medicine”
Hippocrates

1. Introduction
Over 2,500 year ago, Hippocrates noted the potential health
benefits of daily exercise of moderate intensity such as
a simple walk. In the last six decades, and since the
landmark work by Morris and coworkers [1], the plethora of
epidemiologic evidence accumulated supports unequivocally
an inverse, independent, and graded association between
physical activity, health, and cardiovascular and overall
mortality in apparently healthy individuals [2–22] and in
patients with documented cardiovascular disease [9].
The exercise-induced health benefits are in part related
to favorable modulations of cardiovascular risk factors that
have been observed with increased physical activity patterns
or structured exercise programs [10]. Most recently the

discovery that skeletal muscles are capable of communicating
with other tissues by the release of myokines into the
circulation aids to our understanding of the exercise-induced
health benefits on the molecular level. More specifically,
Boström and colleagues [23] identified a new hormone irisin,
named after the ancient Greek goddess of the rainbow and
messenger of the Olympian gods. Irisin is released into the
circulation by the skeletal muscle during exercise and triggers
the transformation of white fat cells to cells that behave
similar to brown fat cells (brown-in-white or brite cells).
Moreover, mice engineered to express high irisin levels in
blood were resistant to obesity and diabetes. These findings
provide a mechanistic explanation for the protection exercise
oﬀers against metabolic diseases and perhaps a network of
other chronic human diseases [23].
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This paper examines the association between physical
activity and mortality risk for apparently healthy populations
and those with chronic health conditions.

2. Occupational and Leisure Time
Physical Activity Studies
In a landmark study, Morris and coworkers reported that
individuals with physically demanding occupations (London mail carriers and double-decker bus conductors) had
approximately 50% lower rates of coronary heart disease
(CHD) when compared to the more sedentary bus drivers
and desk clerks [1]. These findings stimulated worldwide
interest in the relationship between physical activity and
cardiovascular mortality.
Subsequent leisure time physical activity studies and
occupational studies from variety of industries included
postal workers, railroad workers, and farm workers, employees of utility companies, civil servants, longshoremen,
policemen, and firefighters examined the physical activitymortality relationship. Despite the subjective nature of
questionnaires utilized to quantify physical activity, the
overall findings of these studies support a graded reduction
in the risk of coronary heart disease and death with increased
level of physical activity. This association was similar for men
and women regardless of age or other confounding factors
and was as robust as that of established risk factors such as
smoking, hypercholesterolemia, and hypertension [24, 25].
Contradictory to the findings of the aforementioned
studies are those reported in a Finnish study. The rate of
coronary heart disease mortality was greater among lumberjacks compared to less active farmers of the same region [26].
However, these findings must be interpreted with caution.
Although farmers were less active than lumberjacks, they
were not sedentary. Thus, the study compared highly active
individuals (lumberjacks) to somewhat less active (farmers).
This along with the higher fat consumption and smoking
rates among lumberjacks is likely to have attenuated the
positive eﬀects of physical activity in the lumberjacks and
showed more favorable outcomes for the farmers.
Three landmark studies based on over 16,000 Harvard
Alumni [19–21] provided the first evidence of several
essential concepts regarding exercise, fitness, and health.
First, the existence of an exercise threshold was identified,
beyond which health benefits are realized. In this regard,
an exercise intensity of about 5-6 METs and an exercise
volume threshold somewhere between 1,000 to 2000 Kcal per
week were identified for significant reduction in mortality
risk. Second, physical activity necessary for health benefits
is of moderate intensity and volume. Third, the investigators
observed a risk associated with excessive exercise. Mortality
risk tended to increase slightly in those expending more than
3,500 Kcal per week exercising [21]. This will be equivalent to
about 30–35 miles of jogging per week. Forth, mortality risk
was related to caloric expenditure regardless of the type of
activity. When mortality risk was assessed based on diﬀerent
types of physical activity that included walking (miles/week),
stair-climbing (floors), and sports paying, the inverse and
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graded association between mortality risk and volume of
physical activity was again evident and in accord with their
previous findings [19].
Finally, the exercise-related health benefits were only
evident if physical activity was maintained throughout life.
Those who played varsity sports, but did not maintain a
physically active lifestyle had higher mortality rate compared
to those who maintained a physically active lifestyle in
adulthood. Moreover, those who avoided athletics in college
but subsequently took up a more active lifestyle also had
similarly low rates of mortality [20]. This finding suggests
for the first time that the exercise-related health benefits can
be attained at a later age in life. It also casts doubt that
genetic factors that favor athletic abilities are also associated
with better health and longevity. Yet, the influence of genetic
factors in the reduction of the mortality risk cannot be
dismissed. Furthermore, the argument can be made that it
is not the physical activity that provides protection but the
genetic composition of these individuals.
In this regard, the independent association of physical
activity and mortality and the influence of genetic and
other familial factors were assessed in a cohort of samesex twins (7,925 men and 7,977 women). Individuals who
reported engaging in brisk walking for a mean duration of
30 minutes, at least 6 times per month were classified as
physically active. Those who reported no leisure time activity
were classified as sedentary. The remaining individuals were
classified as occasional exercisers. When compared to the
sedentary twins, the adjusted risk of mortality was 33%
lower among the twins who exercised occasionally and 44%
lower among the physically active twins. The investigators
concluded that physical activity is associated with lower
mortality independent of genetic and other confounding
factors [11].

3. Physical Activity and Mortality in Women
The findings of recent large cohort studies in women,
including the Women’s Health Study, the Lipid Research
Clinics Research Prevalence Study, and the Women Take
Heart Project also support an inverse and graded association
between increased physical activity and mortality in women
[7, 8, 13–15]. There is also evidence to support that physical
activity may provide a greater degree of protection in women
than men [13–15]. A noteworthy finding was that sedentary
women who became physically active between a baseline and
a follow-up visit (6 years apart) had 32% and 38% lower
all-cause and cardiovascular mortality rates, respectively,
compared with women who were sedentary at both visits
[15]. This weakens the notion that the higher mortality
reported in sedentary individuals is the consequence of
subclinical diseases and not lack of physical activity per se
(reverse causality).
In summary, the accumulated epidemiological findings
support a strong, inverse, and graded relationship between
volume of physical activity and all-cause mortality in men
and women. The contribution of physical activity to health
outcomes is independent even when the traditional cardiovascular risk markers and genetic factors are considered.
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Moreover, the degree of risk associated with physical inactivity is similar to and in some cases even stronger than the
more traditional cardiovascular risk factors [2, 3, 9, 11–14].
An exercise volume threshold can be defined beyond
which a significant reduction in mortality risk occurs. Such
threshold appears to be at caloric expenditure of approximately 1,000 Kcal per week was defined as the threshold
for an average reduction of 20% to 30% in mortality risk.
Further reductions in risk are observed with higher volumes
of energy expenditure. The independent contribution of the
exercise components, intensity, duration, and frequency to
the reduction of mortality risk is not clear and the need for
more research to better understand the contribution of each
component is emphasized [28].
Finally, it is important to emphasize that occupational
and leisure time studies have used questionnaires to quantify
the physical activity of the cohort. The assessment of physical
activity with this method is subjective and the exercise
volume reported is likely to be overestimated. Although this
may be viewed as a weakness in these studies, the health benefits observed by these studies are likely to be underestimated.

4. Fitness Assessment Studies
More recent studies assessed fitness status by standardized
exercise protocols. Such protocols are designed to progressively increase the workload until the age-predicted
maximal heart rate is achieved or the participant can no
longer continue. The aerobic workload achieved at this level,
referred to as the peak exercise capacity, is expressed in
metabolic equivalents (METs). One MET is equal to 3.5 mL
of O2 /kg/min, the amount of energy expended per kg of body
weight, during one minute of rest. Any activity above resting
requires greater oxygen consumption, and therefore, yields a
higher MET level [29].
Because such exercise tests are designed to push the
participant to exhaustion, fitness assessment by this method
is far more objective than questionnaires. Select studies are
presented here, the findings of which not only supported
those of the occupational and leisure time studies, but more
importantly, enriched our understanding of the association
between exercise or increased physical activity and health
benefits.
Three reports from the Aerobics Center Longitudinal
Study (ACLS) are noteworthy [4–6]. In the first report Blair
and coworkers reported a strong and inverse association
between fitness levels and mortality in a large sample of
mostly white, middle-aged, and relatively healthy individuals
[4]. The largest reduction in mortality was observed between
the least-fit and the next least-fit category (those achieving 6
to 8 metabolic equivalents (METs) versus those achieving <6
METs). Mortality risk continued to decrease with increased
fitness and reached an asymptote at 9 and 10 METs for men
and women, respectively [4]. The mortality risk associated
with fitness was similar to that for cigarette smoking and elevated cholesterol levels [5]. When mortality risk was assessed
in terms of change in exercise capacity between 2 visits (an
average of 5 years apart) a 7.9% reduction in mortality was
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observed for every minute increase in peak treadmill exercise
time between examinations. In addition, unfit men who
improved their fitness status during subsequent visits had a
44% reduction in mortality risk [6]. We also reported similar
finding in a cohort of older veterans who had repeated
exercise tests over time (median 4 years). More specifically,
when compared to the reference group (unfit in both visits)
mortality risk was approximately 60% lower for individuals
who were fit in both visits. For those who were unfit in the
initial visit and improved their fitness status in subsequent
visits mortality risk was 35% lower. For those who were
fit initially, but their fitness declined in subsequent visits
fit mortality risk was approximately 40% lower [30]. These
findings support four concepts: (1) maintaining a relatively
good fitness status over the years lowers mortality risk by
approximately 60%; (2) improvements in fitness status at
any age yields health benefits (35% lower risk); (3) decline
in fitness status results in a concomitant attrition of the
health benefits observed in those who maintained fitness
over the years. However, the fitness-related health benefits
persist to some degree even after fitness status declines. This
and similar reports in women [16] weakens the notion that
the higher mortality reported in sedentary individuals is the
consequence of subclinical diseases and not lack of fitness per
say (reverse causality).
Because exercise capacity can be quantified (peak METs)
when standardized exercise testing protocols are utilized,
several studies expressed this relationship in the context of
survival benefit per MET increase in exercise capacity. The
reduction in mortality risk per MET in these studies has
ranged between 10% and 25%, for individuals with and
without cardiovascular disease [3, 9, 16–18] and regardless
of age, gender, or race [2, 3, 6, 9, 12–14, 16–18].

5. Association of Mortality Risk with
Exercise Type, Duration, and Intensity
Evidence from several studies suggests an independent contribution of the exercise mode and each exercise components
(intensity, duration, frequency) to mortality risk [28].
A great deal of information is available for the association
between aerobic type of activities and mortality risk, while
limited information exists for resistance or weight training.
However, the relatively large Health Professionals’ Followup Study (n = 44 452 men) provides the much needed
information regarding resistance training and mortality risk
association. Based on this study, the reduction in coronary
heart disease risk achieved by participation in resistance
training was similar to that provided by brisk walking and
rowing, but was approximately half of that provided by
running [22]. This, along with a much stronger association
observed between exercise intensity and mortality risk
suggest that exercise intensity may be more important than
duration for lowering the risk of coronary heart disease.
In contrast to these findings [22], exercise duration
was more eﬀective in lowering the risk for coronary events
than exercise intensity in the Women’s Health Study [7, 8].
For the same exercise volume achieved by either higher
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exercise intensity or longer duration, the risk reduction was
substantially greater for exercise duration.
The potential for greater health outcomes associated
with relatively high intensity-short duration exercise training
have generated interest in programs utilizing high-intensity
aerobic interval training. Such training consists of multiple
short bouts of activity (usually 3 to 4 minutes in duration),
followed by approximately equal periods of low-intensity
activity. The intensity is usually >85% of peak oxygen
uptake or peak heart rate. Several studies utilizing such
exercise training have shown significant improvements in
metabolic and cardiovascular parameters in both young
healthy adults and heart failure patients. Compared with
traditional continuous exercise programs, interval training
has resulted in marked improvements in skeletal muscle
capacity for fatty acid oxidation in young women [31]
increases in muscle oxidative capacity in young men [32],
and resting blood pressure reduction in middle-aged and
older individuals [33].
Intuitively, high-intensity training raises safety concerns,
especially in older individuals and those with heart disease. In this regard, a recent study performed in heart
failure patients is noteworthy [34]. Elderly patients with
stable postinfarction heart failure (ejection fraction < 40%)
receiving optimal medical therapy were randomized to either
a moderate continuous exercise program at 70% of peak
heart rate, interval training at 95% of peak heart rate,
or a control group. After 12 weeks, the high-intensity
interval training resulted in greater improvements in aerobic
capacity, mitochondrial function, and skeletal muscle flowmediated dilation. High-intensity interval training induced
reverse left ventricular remodeling and improved cardiac
function. The program was also well tolerated, and quality
of life improved.
Although these findings are impressive, it is imperative
that they be interpreted with caution. Higher exercise
intensities carry an inherent risk of serious complications,
especially for those with compromised cardiac function
and therefore the risk/benefit ratio may be unfavorable for
certain individuals. Finally, it should be emphasized that the
aforementioned findings are based on a few studies with
relatively small number of participants. Larger studies are
needed to confirm their findings.
However, it is important to keep in mind that the interaction between exercise intensity, duration, and frequency is
inextricable. Higher exercise intensity may oﬀer additional
health benefits for some populations while others may benefit more from relatively low exercise intensities and longer
duration. The salient message from these and other reports
[12, 35] is that moderate activity such as brisk walking has a
considerable health benefits and walking or similar activities
a few hours per week should be recommended to all adults,
as suggested in various guidelines [36, 37].

6. Physical Activity and Cardiac Risk Factors
6.1. Obesity. Obesity is defined as the accumulation of excess
body fat usually ≥25% of the total body weight for men and
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Table 1: Classification of body weight and obesity based on BMI
and waist circumference.
Waist
circumference

Obesity BMI
class (kg/m2 )
<18.5

Underweight
Normal

18.5–24.9

Average
Men: ≥94 cm
Increased
25.0–29.9 Women: ≥80 cm

Overweight
Obesity
Moderate
obesity
Severe obesity

Associated
health risk

Men: >102 cm
Moderate
Women: >88 cm

I

30.0–34.9

II

35.0–39.9

High

III

≥40

Very high

≥33% for women [38]. Because direct body fat assessment
is impractical for large populations, body mass index (BMI)
was adopted by The American Heart Association (AHA) as a
practical clinical indicator of adiposity [39]. BMI, calculated
as weight (kg) divided by height (m) squared (kg/m2 ), has
been shown in large epidemiologic studies to correlate well
with total body fat and to be related to cardiovascular and
all-cause mortality [40–42].
The National Heart, Lung, and Blood Institute and World
Health Organization have adapted a single set of cut-points
at 5 BMI internals to classify overweight and obesity [38].
Based on this classification men and women with a BMI ≥
30 kg/m2 are considered obese and at high risk for mortality
(Table 1). However, it is important to mention that BMI,
although practical, it can be misleading especially in athletes
with relatively high lean body mass.
The mechanisms and causes of obesity are poorly understood. All experts agree that obesity is the result of chronic
imbalance between caloric intake and caloric expenditure.
Simply stated it, obesity is the result of chronic imbalance
between energy intake in the form of food and drink, and
total energy expenditure. However, why some people get
fat while others don’t, even when food intake is similar
is poorly understood. This suggests that a chronic energy
imbalance that favors weight gain may be the outcome of
a complex interaction between genetic and environmental
factors [43, 44].
The predominant environmental factors for obesity
appear to be overconsumption of calories and reduction in
physical activity. Of the two, physical inactivity appears to
play the predominant role. According to the USA federal
report on obesity, total caloric intake over the last two
decades has not substantially increased while physical activity
has decreased significantly [45].

7. Physical Activity, Fitness,
Obesity, and Mortality
Obesity and overweight are considered to be leading risk
factors for a number of chronic health conditions, including
diabetes mellitus, hypertension, coronary heart disease, and
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premature mortality. Obesity not only increases coronary
heart disease risk directly, but also enhances it indirectly
through its adverse eﬀects on several established risk factors,
including insulin resistance and hypertension.
Interventional studies show relatively modest weight
reductions achieved with structured programs of physical
activity. However, in a recent trial, cardiac rehabilitation
patients randomized to an intensive counseling, and exercise
program designed to achieve an energy expenditure of 3000
to 3500 kcal/wk or standard cardiac rehabilitation group,
experienced double the weight loss (8.2 ± 4 versus 3.7 ± 5 kg)
[46].
Despite the relatively low exercise-induced weight reduction, findings from large epidemiological studies support
the concept that reduced risk mortality occurs among more
active individuals regardless of body weight [47]. In a large
follow-up study of 25 714 men, higher fitness levels were
associated with lower risk of mortality in normal-weight,
overweight, and obese men [48]. In addition, the higher
mortality risk associated with higher waist circumference
was trivialized after adjustment for fitness [49]. These
investigators suggested that it is as important for clinicians to
assess the fitness status of an overweight or obese patient as it
is to evaluate blood pressure, inquire about smoking habits,
and measure fasting plasma glucose and lipid levels.
Similarly, in two reports from the Nurses’ Health
Study (n = 204 957 combined), after adjustment for age,
smoking status, parental history of coronary heart disease,
menopause, hormonal use, and alcohol consumption, higher
levels of physical activity in women were associated with
reduced mortality risk across all categories of body weight
[50, 51]. It is noteworthy that the mortality risk associated
with obesity was attenuated by higher levels of physical
activity, but was not totally eliminated. Similarly, being lean
did not counteract the increased risk associated with being
physically inactive [50, 51].
Other prospective studies performed over the last decade
have assessed the independent and joint associations between
body weight, fitness, physical activity patterns, and outcomes. The findings of these studies support that both
physical inactivity and excess weight are independently
associated with the increased risk of cardiovascular disease
[52, 53]. However, a consistent finding of these studies is that
fitness attenuated mortality risk regardless of body weight.
When stratified within a given category of body dimensions
(body mass index, waist circumference, or weight), subjects
who are more physically active or fit consistently have a
lower risk for adverse outcomes compared with those who
are inactive or unfit.
Recent epidemiological findings have also drawn attention to an inverse association between body mass index and
mortality in some populations, often termed the obesity
paradox [54–56]. One explanation may be that individuals
within the lowest body mass index category may have had
undefined chronic illness, resulting in nonvolitional weight
loss [55]. This is supported by two recent report from the
Veterans Aﬀairs database. In the first report, the inverse
association between body mass index and mortality observed
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in male veterans was attenuated when fitness levels were
considered suggesting that individuals with low body weight
and low exercise capacity may have had undetected chronic
disease [56, 57]. In the second report, weight gain over a
mean follow-up period of seven years was related to lower
mortality and weight loss was related to higher mortality
when compared with stable weight [57].

8. Hypertension
Chronic hypertension is a major and most common risk factor for developing cardiovascular disease and mortality [58].
The mortality risk doubles for every 20-mm Hg increase in
systolic blood pressure above the threshold of 115 mm Hg
and for every 10-mm Hg increase above the diastolic blood
pressure threshold of 75 mm Hg [59]. Approximately one
third of the adult population in the United States has
hypertension [60] and about 1 billion worldwide, with a
60% increase in the year 2025 [61]. The progressive increase
in blood pressure and consequently, hypertension do not
appear to be a fundamental feature of human aging [62], but
the outcome of lifestyle factors such as diets high in fat, excess
body weight and physical inactivity [61, 62]. Conversely, lowsalt and/or low-fat diets, weight loss and increased physical
activity, contribute significantly to blood pressure control
[61, 63]. Increased fitness can also attenuate the rate of
progression to hypertension [64].

9. Physical Activity,
Fitness, and Hypertension
The significant impact of increased physical activity or
structured exercise programs on blood pressure control
has been consistently documented by a number of wellcontrolled studies. The general conclusion from these studies
is that aerobic exercise training lowers blood pressure in
individuals with stage 1 hypertension by 3.4 to 10.5 mm Hg
for systolic blood pressure and 2.4 to 7.6 mm Hg for diastolic
blood pressure [65–68]. The magnitude of the reduction may
be related to the initial level of blood pressure [69] whereas
the influences of age or gender are not clear [70].
Most of the work regarding exercise-related blood pressure changes has been in individuals with mild to moderate
hypertension. Little is known on the eﬀects of exercise in
individuals with stage 2 hypertension. In this regard, we
studied the eﬀects of moderate-intensity aerobic exercise in
male veterans with stage 2 hypertension and left ventricular
hypertrophy. After 16 weeks of regular exercise we noted
significant reductions in blood pressure and left ventricular
mass regression in these patients. At 32 weeks, blood pressure
in the exercise group was still significantly lower from
baseline even after a 33% reduction in antihypertensive
medication. There were no blood pressure changes in the noexercise group [71].
Some studies suggest that low exercise intensity may be
more eﬀective in lowering blood pressure than high exercise
intensity [69, 72, 73]. Others have noted that the favorable
eﬀects of training on blood pressure are not influenced or are
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only minimally influenced by exercise intensity, frequency,
type, or duration [74]. Overall, the evidence that the blood
pressure response to regular exercise diﬀers according to
training intensity is not convincing [65]. Information on
the exercise-induced blood pressure changes over a 24hour period (ambulatory blood pressure) is limited and
blood pressure reduction is less dramatic than for blood
pressure assessed from a single measurement (mean 3.0and 3.2-mm Hg reductions for systolic and diastolic blood
pressure, resp.) [66, 67]. However, two studies reported
similar reductions of approximately 5–7 mm Hg for systolic
and diastolic blood pressure [75, 76]. We also noted that
daytime ambulatory blood pressure diﬀerences between fit
and unfit prehypertensive men and women (n = 650) were
similar to the blood pressure changes reported after exercise
training [77]. In The HARVEST trial, young hypertensive
patients who engaged in physical activity for at least once a
week during the previous two months exhibited significantly
lower 24-hour and daytime diastolic blood pressure, than the
inactive group [78]. Others reported no significant reduction
in blood pressure [79, 80]. However, in one of the two studies
[80], only nine patients were included and no control group
was used.
Almost all of the information regarding exercise and
blood pressure is derived from aerobic exercises. Information
available on the eﬀects of resistance or strength training
on resting blood pressure is limited and conflicting. The
conclusion of a recent meta-analysis was that the average
systolic blood pressure reduction as a result of resistance
training was 3 mm Hg. This is substantially less than that
reported for endurance exercise [81]. Based on these findings, the recommendation of the American College of Sports
Medicine is that resistance training may serve as an adjunct
to an aerobic-based exercise program for blood pressure
reduction [67].
Despite the limited favorable changes in blood pressure,
strength training is associated with numerous other health
benefits, including reducing the risk of falls by reversing
or attenuating the age-related decline in bone mineral
density, muscle mass, and power [82]. Thus, according to
the recommendations from the American Heart Association
and the American College of Sports Medicine resistance
exercise should be implemented as part of a complete exercise
program [83, 84].

10. Exercise Blood Pressure Response
Evidence supports that the blood pressure response to
submaximal workloads is associated with left ventricular
hypertrophy (LVH). Middle-aged, prehypertensive individuals (n = 790) with similar resting blood pressure who
achieved a systolic blood pressure ≥ 150 mm Hg at the
exercise intensity of 4-5 METs had a significantly higher left
ventricular mass index compared with those with systolic
blood pressure below this level. Furthermore, the risk of LVH
increased 4-fold for every 10-mm Hg rise in systolic blood
pressure beyond the threshold of 150 mm Hg at 5 METs [85].
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The rationale for the exercise systolic blood pressure and
LV mass relationship is that the blood pressure response
at exercise workloads of 4-5 METs reflects daytime blood
pressure during most daily activities. Support for this
contention is provided by the similarity between the exercise
blood pressure at 5 METs and daytime ambulatory blood
pressure obtained in 650 prehypertensive individuals [77,
85]. Thus, it is reasonable to assume that the daily exposure
to relatively high blood pressure provides the impetus for an
increase in LV mass even at the prehypertensive stage.
This exaggerated blood pressure response to exercise
may be modulated by fitness. Exercise capacity is inversely
related to exercise blood pressure and to LV mass [85]. We
reported that the systolic blood pressure of fit individuals
at exercise intensity of 4-5 METs and LV mass index were
significantly lower when compared to the blood pressure and
LV mass index of low-fit individuals. In addition, for every
1-MET increase in the workload achieved, we observed a
42% reduction in the risk for LVH [85]. Finally, 16 weeks of
aerobic training resulted in significantly lower blood pressure
at 3 and 5 METs [86] and regular exercise was associated
with LV mass regression in older individuals with stage
2 hypertension [71]. Others have also reported significant
reductions in blood pressure and regression in LV mass in
older individuals with mild to moderate hypertension, after
aerobic exercise [87].

11. Physical Activity, Fitness, and Mortality
Risk in Individuals with Hypertension
A number of large and well-controlled epidemiologic studies
have reported an inverse and graded association between
exercise capacity and mortality risk in hypertensive individuals [9, 27, 88]. In a cohort of 4,631 hypertensive
veterans with multiple cardiovascular risk factors, we noted
a 13% lower mortality for every 1-MET increase in exercise
capacity. In addition, mortality risk was approximately 34%
to 70% lower in those with an exercise capacity of >5 METs.
When we examined the risk based on fitness status level
(least fit to most fit) and on the presence or absence of
additional risk factors, we observed the following. Among
the least-fit individuals, those with additional risk factors
had a 47% higher mortality rate than those without risk
factors. The increased risk imposed by a low fitness level
and additional cardiovascular risk factors was eliminated
by relatively small increases in exercise capacity, and the
risk declined progressively with higher exercise capacity [27]
(Figure 1).
In a more recent study, we examined the mortality risk
in hypertensive veterans according to fitness status and body
mass index (BMI). Our findings support that the association
between exercise capacity and mortality risk was strong,
inverse and graded, in all BMI categories. For each 1-MET
increase in exercise capacity the adjusted risk was 20% for
normal-weight (BMI < 25); 12% for overweight (BMI: 25–
29.9), and 25% for obese (BMI ≥ 35) [89].
To explore the fitness-fatness and mortality risk relationship further, we asked whether being of normal weight, but
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Mortality risk

participants maintaining normal blood glucose values over a
period of 3 years compared with the metformin or placebo
group [94]. In addition, to prevent one case of diabetes
during a period of three years, 6.9 persons would have to
participate in the lifestyle-intervention program, and 13.9
would have to receive metformin [94].

1.47∗

1.5

1

7

0.97

1

0.66∗

0.5

0.56∗
0.48∗

0
≤5 METs

5.1–7 METs

7.1–10 METs

0.37∗
0.33∗

>10 METs

Risk factors
No risk factors

Figure 1: Mortality risk according to exercise capacity in hypertensive individuals with and without risk factors. Adopted from [27].

low fit carries a more favorable risk than being overweight
or obese, but fit. Compared to the normal weight but
unfit individuals, the mortality risk was 47% and 60%
lower for the overweight-moderate-fit and overweight-highfit individuals, respectively. Similarly, the risk was 55% lower
for the obese-moderate-fit and 78% lower for the obesehigh-fit individuals [89]. These findings suggest that it is
more beneficial to be fit and overweight or obese rather than
normal weight and unfit. Furthermore, it appears that obese
hypertensive individuals may benefit at least as much from
fitness than their overweight or normal weight counterparts.

12. Diabetes Mellitus
Evidence from large cohort studies supports that physical
activity in general provides a highly eﬀective way to delay
or avert the development of diabetes mellitus in both men
and women. The incidence of type 2 diabetes mellitus was
inversely related to leisure time physical activity among men
in the Harvard Alumni Study [90], in US male physicians
[91] and women in the Nurses’ Health Study [92]. The
relative risk for developing diabetes mellitus in women was
inversely related to the level of fitness as well as exercise
volume and intensity in a dose-response fashion. Equivalent
energy expenditures from diﬀerent activities and intensities
conferred similar health benefits.
These epidemiological findings are supported by two
interventional studies. In the Finnish Diabetes Prevention
Study [93], 522 middle-aged, overweight men and women
were randomized to either an intervention group or a
control group. In the Diabetes Prevention Program Research
Group study, 3,234 nondiabetic individuals with elevated
fasting glucose concentrations were randomly assigned to
placebo, metformin, or lifestyle-modification program [94].
In both studies lifestyle interventions of a healthy diet,
weight reduction and increased physical activity resulted in
significantly lower cumulative incidence of diabetes mellitus
than the control group [93, 94] and the group treated
metformin [94]. Lifestyle interventions also resulted in more

13. Physical Activity, Fitness, and Mortality Risk
in Individuals with Type 2 Diabetes Mellitus
Epidemiologic findings also support that increased physical
activity is associated with lower mortality risk in individuals
with type 2 diabetes mellitus. The all-cause mortality risk for
low-fit or sedentary diabetics is more than 2 times higher
compared with physically fit men and women diabetics
regardless of body weight [95–97].
Low physical activity levels and poorer fitness status are
inexorably associated with aging and age-related unfavorable
changes in several physiological and metabolic processes,
including declines in muscle mass, strength, endurance,
and aerobic fitness, with reciprocal increases in adiposity,
insulin resistance, metabolic syndrome, and type 2 diabetes
mellitus [29, 98]. Individuals with diabetes mellitus, in
addition, show an accelerated decline in oxidative capacity
(maximum oxygen uptake), muscle mass, muscle strength,
and glycemic control with aging [99–102]. Reduced exercise
capacity is a strong predictor of all-cause mortality in
older individuals with and without diabetes mellitus [49].
Since aging and reduced exercise capacity often coexist,
and increased fitness is inversely related to mortality risk,
we assessed the relationship between aging and exercise
capacity in older individuals with diabetes mellitus. Our
findings show that greater exercise capacity or fitness is
associated with lower mortality risk in individuals aged 50
to 65 years old as well as those older than 65 with type 2
diabetes mellitus. When fitness categories were considered,
the mortality risk was 30% to 80% lower for those who
achieved more than 4 METs in both age groups.
Because poorer fitness and lower physical activity levels
are strongly associated with aging and age-related unfavorable changes in several physiological and metabolic processes, it is imperative that healthcare providers encourage
a physically active lifestyle regardless of age.
Because African-Americans have a 2- to 6-fold higher
risk for developing diabetes mellitus [103] and approximately double the diabetes mellitus death rate [104] we
probed for racial diﬀerences on the impact of exercise
capacity on mortality risk in the Veterans Exercise Testing
Study [105]. We found that exercise capacity was a strong
predictor of mortality in black and white men with type
2 diabetes mellitus. The age-adjusted reduction was graded
and more pronounced in whites than in blacks; each 1MET increase in exercise capacity yielded 14% and a 19%
lower risk for blacks and whites, respectively. Similarly, the
risks were 34% and 46% lower for moderately and highly fit
blacks versus blacks in the low-fitness category, respectively.
For whites, the comparable reductions were 43% and 67%,
respectively [105].
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Recent evidence form large epidemiologic studies support significantly higher mortality risk only in individuals
with relatively low body mass index (BMI) with no excess
risk associated with overweight or obese individuals. This
puzzling observation, termed obesity paradox [56, 106], has
not been investigated in the context of fitness status in diabetic individuals. We therefore, assessed the interrelationship
between exercise capacity, BMI and mortality risk, in middleaged and older African-American and Caucasian veterans
with type 2 diabetes mellitus [107, 108]. We observed a
significantly higher mortality risk (70%) in those with BMI
within the normal range (18.5–24.9 kg/m2 ) versus heavier
subjects, consistent with the obesity-mortality risk paradoxical association [56, 106, 109]. When probing for racial
diﬀerences, we observed that this paradoxical association was
evident in both races, with a substantially higher mortality
rate in African Americans (95%) than Caucasians (53%).
The lower mortality risk associated with increased fitness
may be modulated by the exercise-related favorable eﬀects on
carbohydrate and fat metabolism. It is known that exercise
is an insulin-independent stimulant of glucose uptake by
the working muscle cells via the GLUT-4 transporter [110].
Exercise-induced translocation of GLUT-4 transporters is
modulated by several factors related to muscular contractions such as increased calcium concentrations [111],
hypoxia [112] and nitric oxide [113]. Exercise training studies support that both aerobic and anaerobic exercise training
regimens improve glucose uptake and insulin sensitivity
[114, 115].
The recent discovery of the hormone Irisin provide a
mechanistic explanation for the protection exercise oﬀers
against metabolic diseases and perhaps a network of other
chronic human diseases [23]. Irisin is released into the
circulation by the skeletal muscle during exercise and triggers
the transformation of white fat cells to cells that behave
similar to brown fat cells (brown-in-white or brite cells).
Moreover, mice engineered to express high irisin levels in
blood were resistant to obesity and diabetes [23].

14. Physical Activity, Fitness, and Lipids
The most consistent findings from epidemiologic studies and
randomized controlled trials supports that aerobic exercise of
adequate intensity, duration, and volume results in favorable
and independent alterations in high-density lipoprotein
(HDL) cholesterol, with less consistency for reductions in
total cholesterol, triglycerides, and low-density lipoprotein
cholesterol concentrations for both normolipidemic and
dyslipidemic individuals [116–118]. Exercise training can
also attenuate the reductions in HDL cholesterol [119, 120]
usually observed with low-fat diets [121, 122].
Overall, no consistent evidence is available to indicate
that HDL cholesterol changes related to exercise are associated with age, ethnicity, or gender [118]. However, greater
HDL cholesterol changes in men versus women, particularly
when exercise is combined with a prudent diet, have been
reported by some [119, 122], but disputed by others [123,
124]. Some studies suggested that exercise training does not
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appear to improve HDL cholesterol concentrations beyond
the improvements seen with hormone replacement therapy
[125], whereas others have shown synergistic eﬀects between
hormone replacement therapy and exercise training [126].
Epidemiological and interventional study evidence support that the magnitude of the changes in HDL cholesterol
is related more to the volume of exercise than the intensity
[116–118]. The exercise volume for achieving significant
HDL cholesterol changes is estimated at 1000 to 1500 kcal/wk
[127]. This parallels an earlier study in which a mean
estimated weekly energy expenditure of 1245 kcal for individuals running 7 to 10 miles per week (average, 9 miles)
and 1688 kcal for those running 11 to 14 miles per week
(average, 12 miles) resulted in 7% and 11% increases in
HDL cholesterol concentrations, respectively [128]. A doseresponse relationship between the volume of exercise and
HDL cholesterol changes has also been suggested by this
study. For each mile increase in weekly distance, HDL
cholesterol concentration increased 0.31-mg/dL. Compared
with the sedentary group, HDL cholesterol concentrations
were 7%, 11%, 12%, and 19% higher for individuals in the
groups running average distances of 9, 12, 17, and 31 miles
per week, respectively [128]. Similar findings were reported
by others [128–131]. In women, menopausal status does not
appear to influence this dose-response relationship [132].

15. Physical Activity, Fitness, and Inflammation
Although the mechanisms of atherosclerosis are not completely understood, it is well accepted that atherosclerosis
is largely a chronic inflammatory disease of the arterial
wall known as the “response-to-injury” theory [133–135].
This theory states that atherosclerosis develops as a result
of repetitive injury and ongoing inflammatory process of
the arterial endothelium, initiated by a pathogen. A number
of blood markers have been identified that are associated
with inflammation, most notably white blood cell count, Creactive protein (CRP), homocysteine, fibrinogen, and other
proteins involved in the immune response. The most widely
studied inflammatory blood marker is CRP [136].
Several studies have shown that elevated levels of CRP
are directly associated traditional cardiac risk factors and
independently increase the risk of cardiovascular disease and
mortality in both healthy individuals and patients with existing cardiovascular disease [137–141]. Acute exercise induces
a transient inflammatory response, including heightened
CRP concentration. This is most likely due to joint and muscle inflammation after vigorous activity. However, regular,
sustained exercise has been shown to suppress inflammation.
The findings of epidemiological studies consistently support
of an inverse association between CRP, other inflammatory
markers, and fitness. CRP levels of those engaging in
regular exercise are approximately 30% to 50% lower when
compared to sedentary individuals [142–144]. Collectively,
these [142–144] and other findings [10] support that the
health benefits (including lower mortality risk) associated
with increased fitness may be explained in part by the inverse
association between fitness and inflammatory markers.
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16. Risk of Death during Physical Activity
The potential for death is inherent in structured exercise
programs or physical exertion. The first death mentioned as
a result of physical exertion is recorded by the Greeks. Legend
has it that Phidippides ran from the battlefield of Marathon
to Athens (approximately 26 miles away) to carry the news to
the Athenians that they were victorious against the invading
Persians. He reached Athens in perhaps 3 hours, delivered his
message, and died shortly thereafter from exhaustion.
Was it the 26-mile run that killed Phidippides? Not
likely! Less known is the fact that, only days prior to the
battle at Marathon, Phidippides was sent to Sparta to ask for
help. He ran the rugged, mountainous 140-mile course in
about 36 hours to deliver the message. Afterwards, Phidippides ran that same 140-mile trail back to Athens with the
disappointing news that the Spartans refused to send warriors to help the Athenians. A few days later he was in
the battle of Marathon where, in all likelihood, Phidippides
had been carrying messages back and forth to the diﬀerent
generals on the field during the day’s battle. It was at the end
of that last day when he was charged with running to Athens
to deliver the victorious news [29].
Although we will never know exactly what killed Phidippides, the numerous modern marathon and ultramarathon
races run by millions of runners annually are proof that
humans are capable of such a task when trained properly. On
the other hand, the occasional death of a runner reminds us
of our vulnerabilities.
Almost all exercise-related deaths in previously asymptomatic adults without prior history of coronary heart
disease have been the result of atherosclerotic plaque rupture
in one of the coronary arteries that led to an acute
coronary thrombosis [145–148]. Recent findings also suggest
that demand ischemia (i.e., ischemia due to an imbalance
between oxygen supply and demand) may be implicated in
exercise-related acute coronary events during long-distance
running [149].
Because the most common cause of cardiac complications is atherosclerotic coronary artery disease, the risk
of exercise varies according to the population. In older
populations where the prevalence of coronary atherosclerotic
disease is high, the risk of death during exercise or physical
exertion will be correspondingly high [150]. In apparently
healthy, young individuals (<35 years), sudden death is often
due to hypertrophic cardiomyopathy [150]. Interestingly,
cardiac arrest, most commonly attributable to hypertrophic
cardiomyopathy or atherosclerotic coronary disease, occurs
primarily among male marathoners [149].
Several studies have also shown an inverse association
between the risk of an event and the fitness status of the
individual [151–154]. The risk of a cardiac event during
physical exertion for sedentary individuals is reported to be
approximately 2.5 to 30 times higher when compared to
those who engage even moderate levels of physical activity
(twice weekly) [152–154].
Despite this risk, the exercise-related cardiac event is
relatively rare even in high-risk populations. The incidence of
exercise-related deaths is the Rhode Island study [155] over
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a five-year period was 1 death per year for every 15,240 male
joggers with no know coronary heart disease and 1 death
per year for every 7,620 in those with known coronary heart
disease. In general, the rate of sudden cardiac death and other
cardiac events during exercise is estimated to be between 0
and 2 per 100,000 hours of exercise in the general population
and 0.13 to 0.61 per 100,000 hours in cardiac rehabilitation
programs [156, 157]. More recent evidence from a large
cohort on marathon and half marathon runners concur with
these findings. The incidence rates of cardiac arrest and
sudden death during long-distance running races were 1 per
184,000 and 1 per 259,000 participants, respectively. This
translates roughly into 0.2 cardiac arrests and 0.14 sudden
deaths per 100,000 runner-hours at risk, using average
running times of 4 and 2 hours for the marathon and halfmarathon, respectively [149].
In conclusion, it is clear that physical exertion is associated with a transient increase in risk for cardiac events. This
risk is significantly higher for older and sedentary individuals
engaging in an exercise program. Therefore, it is prudent
that such individuals consult their physician to evaluate
the presence of subclinical coronary artery disease prior to
engaging in an exercise program.

17. Exercise Recommendations for
Health Benefits
The plethora of information and (at time misinformation)
regarding exercise, fitness, and health within the last few
decades is stunning and overwhelming for most individuals.
To minimize confusion for the patients, reduce the risk of
injury, and to maintain exercise eﬃcacy, health care providers
must view exercise as an intervention similar to prescribing
medication. The mode of exercise, its frequency, intensity
and duration should be considered carefully. Moreover,
exercise should be tailored to meet an individual’s needs and
abilities. This is especially true for special populations such
as elderly, overweight or obese, hypertensive, and diabetic
individuals. The current recommendations from the American Heart Association and the American College of Sports
Medicine for middle-aged adults and older individuals [83,
84] stated below should be followed.
(i) Exercise should be primarily aerobic, supplemented
by muscle-strengthening activities.
(ii) The exercise intensity should be moderate (brisk
walking at 15 to 20 minutes per mile) for most
individuals and at even lower intensities for those
unable to sustain such walking speeds. Moderateand vigorous-intensity (jogging) activities can be
combined for younger individuals or those able to
sustain such intensities.
(iii) The exercise duration should consist of ∼30 minutes
of continuous or accumulated physical activity on
most, and preferably all, days of the week.
(iv) A gradual increase in the minimum exercise volume
is recommended to maximize health benefits. In
addition, a minimum of 2 days per week of light
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weight-resistance exercises involving the major muscle groups and designed to maintain or increase
muscular strength and endurance is encouraged.
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